Seoul National University Hospital
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 501
- Market Cap
- -
- Website
- https://www.snubh.org
Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC)
Not Applicable
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Procedure: Percutaneous ethanol injection therapyProcedure: Operation
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT00357422
- Locations
- π°π·
Seoul NUH, Seoul, Chongno-gu, Korea, Republic of
Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs
Phase 3
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Procedure: Transarterial chemoembolizationProcedure: Percutaneous ethanol injection therapy
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT00357474
- Locations
- π°π·
Seoul NUH, Seoul, Chongno-gu, Korea, Republic of
Fractional Flow Reserve-guided Provisional Side Branch Intervention
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2011-07-18
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT00351780
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Safety and Immunogenicity of CJ-50300
Phase 1
Completed
- Conditions
- Smallpox
- First Posted Date
- 2006-06-14
- Last Posted Date
- 2007-04-19
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT00336635
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
- Conditions
- Bipolar DisorderSchizophrenia
- First Posted Date
- 2006-05-26
- Last Posted Date
- 2010-07-23
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT00330226
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia
Completed
- Conditions
- SchizophreniaHallucinations
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2009-09-16
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00328952
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
- First Posted Date
- 2006-05-19
- Last Posted Date
- 2008-10-29
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 61
- Registration Number
- NCT00328367
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion
Phase 2
Terminated
- Conditions
- Myocardial Infarction
- First Posted Date
- 2006-03-28
- Last Posted Date
- 2006-03-28
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT00307879
- Locations
- π°π·
Seoul National University Hospital, Yon-Gon Dong, Chongno-Gu, Seoul, Korea, Republic of
Effects of Celecoxib After Percutaneous Coronary Intervention
- First Posted Date
- 2006-02-16
- Last Posted Date
- 2011-07-21
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 260
- Registration Number
- NCT00292721
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
Phase 4
Completed
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: Pegylated Interferon-alpha2a
- First Posted Date
- 2006-02-14
- Last Posted Date
- 2011-07-21
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT00291616
- Locations
- π°π·
Seoul National University Hospital, Seoul, Chongno-gu, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath